Rare histologic subtypes, such as SMARCB1-deficient renal medullary carcinoma, translocation RCC, and collecting duct carcinoma, often express distinct biomarkers that are less prevalent in ccRCC. This evidence concerns the gene SMARCB1 and kidney medullary carcinoma.